Taken together, these results suggest a surprising role for maternal–fetal AHR signaling in NEC, and raise the possibility that A18 can serve as an agent that can be administered either during pregnancy or postnatally for the prevention and treatment of this devastating disease. This evidence concerns the gene AHR and necrotizing enterocolitis.